New Jersey R&D Tax Credit: Does Your Business Qualify?

The New Jersey R&D tax credit gives qualifying businesses a dollar-for-dollar reduction in their state tax liability equal to 10% of qualified research expenses beyond a base amount, with the flexibility to carry unused credits forward for 7 to 15 years depending on your industry.

Key Takeaways:

• New Jersey businesses conducting qualified research can claim a 10% state credit on top of federal R&D credits
• The credit applies to C corporations and S corporations with activities performed within New Jersey
• Recent federal tax law changes restored immediate expensing of R&D costs, making credits more valuable
• Tech and biotech startups can monetize unused credits through the NOL program at 80% of face value
• You must use the same calculation method (Regular or Alternative Simplified Credit) as your federal return

Why New Jersey Businesses Are Leaving Money on the Table

Walk into any pharmaceutical lab in Princeton. Talk to software developers in Jersey City. Visit manufacturers in Newark.

They’re all doing the same thing. Spending money to make their products better. Figuring out how to reduce defects. Testing new formulas.

Most of them don’t realize they’re sitting on a gold mine.

New Jersey is home to more scientists and engineers per square mile than anywhere else in America. Over 3,200 life science establishments call this state home. Eight of the top 10 pharmaceutical companies worldwide have major operations here. And yet, thousands of businesses miss out on tax credits they’ve already earned just by doing what they do every day.

Here’s what’s really happening: The federal government gives you a credit for R&D. New Jersey adds another one on top. But the state credit doesn’t work exactly like the federal version, and that’s where businesses get tripped up.

How the New Jersey R&D Tax Credit Actually Works

The credit is straightforward on paper. You get 10% of your qualified research expenses that exceed your base amount. Plus another 10% of basic research payments you make to universities or research organizations.

The calculation mirrors IRC Section 41 but only counts research performed in New Jersey. Your engineers working in Trenton? They count. Contractors you hired in California? They don’t.

Think of it this way: You’re already claiming the federal R&D credit. New Jersey says, “If you did that research here, we’ll give you more money.” It stacks. And since 2018, you’ve had more options for how to calculate it.

The Two Calculation Methods You Need to Know

You can’t just pick whichever method gives you a bigger credit. That’s the catch.

Whatever method you used federally, that’s what you use for New Jersey. If you went with the Regular Credit Method on your federal return, you use the Regular Method here. Chose Alternative Simplified Credit federally? Same thing for New Jersey.

The Regular Method looks at your historical spending patterns. It compares your current research expenses to a base period. Works great if you’re an established company with a track record.

The Alternative Simplified Credit is simpler. It’s 10% of your current year’s qualified research expenses minus 50% of your average QREs from the prior three years. Newer companies without much history prefer this route.

Before 2018, New Jersey only offered the Regular Method. Companies with high gross receipts relative to their research spending got squeezed out. That legislative change opened doors for a lot more businesses.

Feature	Regular Credit Method	Alternative Simplified Credit
Calculation	10% of QREs over base amount (historical average)	10% of QREs over 50% of prior 3-year average
Best For	Established companies with historical data	Growing companies or those with limited history
Requirements	Must have fixed base percentage calculation	Simpler calculation, easier documentation
Flexibility	Can produce larger credits if spending is growing	More predictable, less administrative burden

What Counts as Qualified Research in New Jersey

The activities that qualify mirror the federal four-part test. Your project needs a permitted purpose, must be technological in nature, needs to eliminate uncertainty, and has to involve experimentation.

Translation: You’re trying to create something new or improve something existing. It involves science or engineering. You don’t know if it’ll work. You’re testing different approaches.

A biotech company developing a new drug formulation? Qualifies. Software developers creating AI models? Counts. Manufacturers redesigning production processes to reduce waste? You’re in.

Job shops doing precision metal work qualify. Plastic injection molding companies improving their processes qualify. Food and beverage companies testing new ingredient combinations qualify.

Here’s what doesn’t work: Market research. Routine data collection. Adapting existing products without technical uncertainty. Management studies. Quality control testing after you’ve already figured out the process.

The Expenses That Count

Four categories make up your qualified research expenses:

Wages for employees actually doing the research, their direct supervisors, and support staff directly helping with qualified activities. That senior engineer tweaking the production line? Her salary counts. The CFO approving the budget? His doesn’t.

Supplies used or consumed during research. Raw materials for prototypes. Testing supplies. Things that get used up.

Computer rental or lease costs for equipment used in research. If you’re leasing servers to run simulations, that’s eligible.

Contract research expenses at 65% of what you actually paid. You hire a university lab to test your new formula? You can claim 65% of that cost.

Recent Federal Changes That Make This Tax Credit More Valuable

July 2025 changed everything for R&D tax planning.

Congress passed the One Big Beautiful Bill Act. Buried in there was the fix businesses had been begging for since 2022: immediate expensing of domestic R&D costs is back.

From 2022 through 2024, you had to capitalize and amortize R&D expenses over five years. It was killing cash flow. Companies were paying taxes on income they hadn’t really generated because their deductions were spread out.

Now? Starting in 2025, you deduct domestic R&D expenses the year you spend them. Just like before 2022.

Here’s why that matters for New Jersey businesses: The R&D tax credit becomes more valuable when you can deduct your expenses immediately. You’re not waiting five years to realize the full benefit. You get the deduction now AND the credit now.

Small businesses with less than $31 million in average annual gross receipts can even go back and amend their 2022, 2023, and 2024 returns. Larger companies can accelerate their remaining unamortized R&D expenses into 2025 and 2026.

This is a fundamental shift in cash flow. Companies that were watching money evaporate into future-year deductions suddenly have options.

Form 306: Filing Your New Jersey R&D Credit

You file Form 306 with your Corporation Business Tax return. Not complicated, but precision matters.

You’ll need to attach a copy of federal Form 6765 as filed with the IRS. The state wants to see you claimed the federal credit. They’re checking that your methods match.

Cannabis businesses get special treatment. If federal law disallowed your R&D expenses because cannabis is a controlled substance, New Jersey lets you include them anyway. You attach a rider showing the calculations as if Section 280E didn’t exist.

Combined groups have extra steps. Members sharing credits need to coordinate. Those opting not to share need to fill out different sections of the form.

Filing deadline is when your corporate return is due. Miss that, and you’re stuck. No credit for that year.

The Carryforward Rules You Need to Understand

Can’t use the full credit this year? No problem. Well, mostly no problem.

Standard carryforward is seven years. You’ve got seven years to use those credits against future tax liability.

But if you’re in one of six specific technology fields, you get 15 years. Those fields are:

• Advanced computing
• Advanced materials
• Biotechnology
• Electronic device technology
• Environmental technology
• Medical device technology

Why the difference? New Jersey wants to incentivize exactly the industries where it’s strongest. The state has the highest concentration of pharmaceutical and biotech companies in America. They’re protecting that advantage.

S corporations face a unique limitation. The credit can’t reduce your tax below the statutory minimum. So for many S corps, the credit gets carried forward until you elect to be taxed as a C corporation or join a combined group.

Business Type	Credit Availability	Carryforward Period	Special Notes
C Corporation	Full credit available	7 years (standard) or 15 years (tech fields)	Can offset entire net income component of CBT
S Corporation	Limited to NJ tax liability	7 years (standard) or 15 years (tech fields)	Cannot pass through to shareholders
Partnership	Not available to entity	N/A	Corporate partners can claim their share
Tech/Biotech Startup	Full credit available	Can sell via NOL program	80% of value if approved by NJEDA

The NOL Program: Turning Credits Into Cash Before Profitability

Here’s where New Jersey separates itself from other states.

You’re a tech startup. Not profitable yet. You’re generating R&D credits but have no tax liability to offset. In most states, you wait.

Not here.

The New Jersey Economic Development Authority runs the Technology Business Tax Certificate Transfer Program. Everyone calls it the NOL program. It lets qualifying companies sell their unused R&D credits and net operating losses to profitable corporations.

You get at least 80 cents on the dollar. Turn those paper credits into actual cash you can use today.

Since 1999, nearly 600 companies have participated. The program generated $28.1 billion in economic impact. Companies that use it have a 72% survival rate. Industry average for tech startups? 36%.

That’s not coincidence. Cash flow determines whether startups survive.

Who Qualifies for the NOL Program

Technology and biotechnology companies with fewer than 225 US employees total. That includes your parent company and all subsidiaries.

You need to own, have filed for, or license proprietary intellectual property. Patents or registered copyrights.

Can’t have positive net operating income in your last two full years. Your parent company can’t have positive income either.

Employee requirements vary by age: Fewer than three years old? One full-time New Jersey employee. Three to five years? Five employees. More than five years? Ten employees.

Up to $75 million is available annually. $15 million is set aside for businesses in Innovation Zones (Newark, Camden, New Brunswick), Opportunity Zones, or certified minority/woman-owned businesses.

Applications open in May. Deadline is June 30. You compete with other applicants if demand exceeds the pool.

The program charges $1,000 application fee. If your award exceeds $100,000, there’s a 1% approval fee capped at $20,000 total.

New Jersey’s Innovation Ecosystem Makes This Credit More Valuable

Context matters. You’re not claiming this credit in a vacuum.

New Jersey hosts Johnson & Johnson, Merck, Bristol Myers Squibb, and hundreds of smaller biotech companies. The state has 46 teaching hospitals. Over 3,100 active clinical trials. Five medical schools producing talent continuously.

Rutgers, Princeton, Stevens Institute. They’re not just training grounds. They’re research partners. The university collaboration piece of the R&D credit exists because these partnerships generate real innovation.

The ON3 campus in Nutley. The NEST in Kenilworth with 1.2 million square feet of lab space. South Jersey Technology Park at Rowan. Ready-to-go infrastructure for companies scaling up.

When you’re claiming the R&D credit here, you’re embedded in an ecosystem designed to support exactly what you’re doing. Access to talent, to partners, to specialized service providers who understand this space.

That geographic concentration creates advantages. Your competitors in Boston pay more for lab space. San Francisco rent eats your runway. New Jersey offers sophisticated infrastructure at competitive prices with faster access to markets and regulators.

Industries Getting the Most Value From New Jersey R&D Credits

Pharmaceuticals and biotechnology lead obviously. Drug development, clinical trials, biologics manufacturing. Companies like Legend Biotech expanding CAR-T manufacturing. PTC Therapeutics building gene therapy facilities. Amicus Therapeutics constructing research centers.

Software and AI companies increasingly qualify. You’re not just coding. You’re developing machine learning models, training algorithms, creating novel approaches to data processing. Apprentice in Jersey City optimizes pharmaceutical manufacturing with AI. That’s qualified research.

Advanced manufacturing captures huge benefits. Precision metalworking. Composite materials development. Robotics integration. Process automation. Oishii in Jersey City uses advanced robotics for vertical farming. Qualifies.

Medical device companies are natural fits. Development cycles involve extensive testing, regulatory compliance, design iterations. Every prototype is experimentation.

Food and beverage companies testing new formulations, improving shelf life, developing packaging innovations.

Engineering firms designing custom solutions, whether for civil projects, electrical systems, or mechanical innovations.

The common thread: You’re solving problems where the solution isn’t obvious, using systematic experimentation rooted in hard sciences.

Common Mistakes That Cost Businesses Money

Waiting too long to start tracking. You can’t reconstruct contemporaneous documentation years later. Start documenting projects when they begin.

Thinking only scientists qualify. Your engineers count. Technicians performing tests count. Supervisors overseeing qualified research count.

Missing contract research expenses. You paid another company to do research for you? That’s 65% eligible.

Forgetting about supply costs. All those materials consumed during testing? Eligible.

Not coordinating federal and state calculations. Your methods must match. File federal first, then use that as your New Jersey template.

Mixing up which expenses went to New Jersey research versus elsewhere. The state only credits in-state activity. Your multi-state operations need careful allocation.

Failing to maintain proper records. Employee time logs. Project descriptions. Technical uncertainty documentation. Budget allocation. The IRS and state auditors want proof.

Missing the tech field designation for 15-year carryforward. Check that box if you qualify. The difference between 7 and 15 years is substantial.

Why Professional Help Pays for Itself

The R&D credit is one of the most scrutinized tax benefits. The IRS conducts more audits on this than almost anything else.

A professional R&D tax credit firm brings three things you can’t easily replicate:

Technical expertise. They have engineers on staff who understand your industry. They can identify qualifying activities you missed because they’ve seen your type of work before.

Tax law mastery. The interaction between IRC Section 41, Section 174, Section 280C, and state law creates complexity. Specialists navigate that daily.

Audit defense. When the state or IRS questions your credit, you need documentation that holds up. Professional firms build audit-proof files from the start.

The typical return on engaging a specialist is 10X to 20X their fee. They find credits you didn’t know existed. They structure your documentation properly. They defend you if challenged.

Jim Hoopes from Eide Bailly puts it directly: “The businesses of the future don’t simply adopt the status quo, but instead look for ways to expand what they’ve done and create new ideas. As your business works to improve existing products and services and develop new ideas, you may be eligible for the research and development tax credit.”

Most firms work on contingency for initial feasibility studies. They only get paid if they find credits for you. That’s how confident they are they’ll uncover value.

Taking Action on Your New Jersey R&D Tax Credit

Start with a simple question: Are you improving products, processes, or techniques through scientific experimentation?

If yes, you probably qualify.

Second question: Are you documenting that work?

If no, start today. Time tracking doesn’t need to be burdensome. Project logs. Meeting notes. Design iterations. Test results. Budget allocations. Capture it as you go.

Third: Talk to someone who specializes in R&D credits. Not your regular CPA unless they focus on this specifically. Find a firm with technical staff, industry experience, and audit defense capabilities.

The 2025 changes to Section 174 created a limited-time opportunity. Small businesses can amend past returns. Larger companies can accelerate deductions. That window won’t stay open forever.

For New Jersey tech and biotech companies specifically, the NOL program application deadline is June 30 each year. Miss it, wait another year. That’s 12 months of cash flow you could have had.

Your competitors are claiming these credits. They’re using that cash to hire engineers, fund trials, scale production. Every dollar you leave on the table is a dollar funding someone else’s growth.

The New Jersey R&D tax credit isn’t a handout. It’s money you earned by taking risks to innovate. The state designed this program specifically to keep companies like yours here and growing. Use it.

New Jersey R&D Tax Credit FAQs

R&D Tax Credits by State

Citations

• New Jersey Department of Treasury. (n.d.). The New Jersey Research and Development Tax Credit – Technical Bulletin TB-114. https://www.nj.gov/treasury/taxation/pdf/pubs/tb/tb114.pdf
• New Jersey Economic Development Authority. (2025, August 3). Technology Business Tax Certificate Transfer (NOL) Program. https://www.njeda.gov/nol/
• New Jersey Department of Treasury. (2024). Form 306: Research and Development Tax Credit. https://www.nj.gov/treasury/taxation/pdf/current/cbt/306.pdf
• Kahnlitwin. (n.d.). Section 174 Repeal: R&E Expensing Returns in 2025. https://kahnlitwin.com/blogs/tax-blog/section-174-fixed-what-businesses-need-to-know-about-r-e-expensing-changes
• ABGI USA. (2025, October 8). Latest Updates on Section 174: Congress Acts on R&D Tax Law Changes. https://abgi-usa.com/section174/latest-and-greatest
• New Jersey Economic Development Authority. (2025, July 9). Life Sciences in New Jersey. https://www.njeda.gov/life-science/
• Choose New Jersey. (2024, March 29). New Jersey’s Life Sciences Industry. https://choosenj.com/key-industries/life-sciences/
• New Jersey Economic Development Authority. (2025, May 20). NJEDA’s NOL Program Generated $28.1 Billion in Economic Impact. https://www.njeda.gov/njedas-nol-program-generated-28-1-billion-in-economic-impact-and-supported-nearly-600-companies/